Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Taletrectinib

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nuvation Bio Initiates First Patient Enrollment In Ibtrozi
    Nuvation Bio Initiates First Patient Enrollment In Ibtrozi

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250929100711/en/Nuvation-Bio-Enrolls-First-Patient-in-TRUST-IV-Phase-3-Study-of-IBTROZI-taletrectinib-for-the-Adjuvant-Treatment-of-ROS1-Positive-Early-Stage-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    30 Sep 2025
    Share Share
    Nuvation Bio Gets Japan Nod for IBTROZITM in Advanced ROS1+ NSCLC
    Nuvation Bio Gets Japan Nod for IBTROZITM in Advanced ROS1+ NSCLC

    19 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250918983094/en/Nuvation-Bio-Receives-Approval-from-Japans-Ministry-of-Health-Labour-and-Welfare-for-IBTROZITM-for-Patients-with-Advanced-ROS1-positive-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    19 Sep 2025
    Share Share
    Nuvation Announces Data from Pivotal Clinical Studies of Ibtrozi
    Nuvation Announces Data from Pivotal Clinical Studies of Ibtrozi

    07 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250907734789/en/Nuvation-Bio-Announces-New-Data-from-Pivotal-Clinical-Studies-of-IBTROZI-taletrectinib-in-Advanced-ROS1-Positive-Non-Small-Cell-Lung-Cancer-at-2025-World-Conference-on-Lung-Cancer

    BUSINESSWIRE
    07 Sep 2025
    Share Share
    Nuvation Bio Reveals New IBTROZI Data at WCLC and ESMO Congresses
    Nuvation Bio Reveals New IBTROZI Data at WCLC and ESMO Congresses

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805634510/en/Nuvation-Bio-To-Present-New-Data-on-IBTROZI-taletrectinib-in-Advanced-ROS1-Positive-Non-Small-Cell-Lung-Cancer-at-WCLC-and-ESMO-Annual-Congresses

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    Taletrectinib Added to NCCN Guidelines for ROS1+ NSCLC Cancer
    Taletrectinib Added to NCCN Guidelines for ROS1+ NSCLC Cancer

    24 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250624605890/en/Nuvation-Bio-Announces-National-Comprehensive-Cancer-Network-Adds-Taletrectinib-IBTROZI-as-Preferred-Option-to-Clinical-Practice-Guidelines-in-Oncology-for-Advanced-ROS1-Non-Small-Cell-Lung-Cancers

    BUSINESSWIRE
    24 Jun 2025
    Share Share
    Onco360 Selected as National Specialty Pharmacy for Ibtrozi™
    Onco360 Selected as National Specialty Pharmacy for Ibtrozi™

    16 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/16/3099726/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-IBTROZI-taletrectinib-Manufactured-by-Nuvation-Bio-Inc.html

    GLOBENEWSWIRE
    16 Jun 2025
    Share Share